MACKANESS JAMES H (Chief Financial Officer) sold 9.6% of their position (13.53K shares) of SOLENO THERAPEUTICS INC on the open market
Open‑market sale worth $641.8K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 8/30/2024ACC: 0001415889-24-022650
Officer· Chief Financial Officer
Since Nov 2019
-13.53K
Net shares
Net seller
$641.8K
Total sold
4
Open market trades
0B · 4S
4
Total transactions
13.53K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
−3.56K
Price / share
$47.19
Trade value
$168.05K
% of position
2.5%
8/28/2024
140.78K→137.22K
Common Stock
Direct
Shares
−3.10K
Price / share
$48.03
Trade value
$148.88K
% of position
2.3%
8/28/2024
137.22K→134.12K
Common Stock
Direct
Shares
−5.59K
Price / share
$47.16
Trade value
$263.86K
% of position
4.2%
8/29/2024
134.12K→128.52K
Common Stock
Direct
Shares
−1.27K
Price / share
$47.83
Trade value
$60.99K
% of position
1.0%
8/29/2024
128.52K→127.25K
Total
Net shares
−13.53K
Net value
-$641.78K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/28/2024 | S · Sale | −3.56K | $47.19 | $168.05K | 2.5% | 140.78K | 137.22K |
| Common Stock Direct | 8/28/2024 | S · Sale | −3.10K | $48.03 | $148.88K | 2.3% | 137.22K | 134.12K |
| Common Stock Direct | 8/29/2024 | S · Sale | −5.59K | $47.16 | $263.86K | 4.2% | 134.12K | 128.52K |
| Common Stock Direct | 8/29/2024 | S · Sale | −1.27K | $47.83 | $60.99K | 1.0% | 128.52K | 127.25K |
| Total | −13.53K | -$641.78K | ||||||
Derivative Transactions0
No derivative transactions reported